Stereoselective oxidation metabolism of 20(S)-protopanaxatriol in human liver microsomes and in rats

被引:12
|
作者
Wang, Wenyan [1 ]
Ni, Yingying [1 ]
Wang, Li [1 ]
Che, Xin [1 ]
Liu, Wanhui [1 ]
Meng, Qingguo [1 ]
机构
[1] Yantai Univ, Sch Pharm, Yantai 264005, Peoples R China
基金
中国国家自然科学基金;
关键词
20(S)-Protopanaxatriol; enzyme kinetics; liver microsomes; metabolite identification; P450; isoforms; stereoselectivity; HUMAN CYTOCHROME-P450 ENZYMES; MICROBIAL TRANSFORMATION; INTESTINAL BACTERIA; MASS-SPECTROMETRY; FATTY-ACID; IN-VITRO; PROTOPANAXATRIOL; GINSENOSIDE; IDENTIFICATION; ENANTIOMERS;
D O I
10.3109/00498254.2014.986562
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
1. In this study, the oxidative metabolites of 20(S)-protopanaxatriol (PPT) were identified in human liver microsomes (HLMs) and in rats using liquid chromatography-electrospray ionization tandem mass spectrometry. 2. Twelve oxidative metabolites were found in HLM, eight of which have not been previously reported. Twenty-four oxidative metabolites were found in rat feces after oral administration and 20 of these, including six found in HLM, were first reported. The results indicated PPT was more extensively metabolized in rats than in HLM. C20-24 epoxides, a pair of epimers (namely, M1-1 and M1-2) were the major metabolites, and other metabolites were derived from their further metabolism. 3. Enzyme kinetics experiments showed that the apparent formation V-max of M1-1 was 10.4 folds and 2.4 folds higher than that of M1-2 in HLM and in rat liver microsomes (RLMs), respectively. The depletion rate of M1-2 was 11.0 folds faster than M1-1 in HLM, and was similar in RLM. Hence, the remarkable species differences of PPT metabolism mainly resulted from the stereoselective formation and further metabolic elimination of M1-1 and M1-2. 4. Chemical inhibition study and recombinant human P450 isoforms analysis showed that CYP3A4 was the predominant isoform involved in the oxidative metabolism of M1-1 and M1-2.
引用
收藏
页码:385 / 395
页数:11
相关论文
共 50 条
  • [21] Metabolism and bioactivation of the tricyclic antidepressant amitriptyline in human liver microsomes and human urine
    Zhou, Xin
    Chen, Chang
    Zhang, Fangrong
    Zhang, Yang
    Feng, Yuling
    Ouyang, Hui
    Xu, Yong
    Jiang, Hongliang
    BIOANALYSIS, 2016, 8 (13) : 1365 - 1381
  • [22] Metabolic detoxification of bakuchiol is mediated by oxidation of CYP 450s in liver microsomes
    Hu, Xiao-Jing
    Zhang, You-Bo
    Zhao, Zi-Jing
    Zhang, Lei
    Wang, Qi
    Yang, Xiu-Wei
    FOOD AND CHEMICAL TOXICOLOGY, 2018, 111 : 385 - 392
  • [23] Stereoselective in vitro metabolism of cyproconazole in rat liver microsomes and identification of major metabolites
    He, Rujian
    Fan, Jun
    Chen, Ran
    Guo, Dong
    Zhao, Mengjiu
    Zhang, Zhifeng
    Liang, Chuying
    Chen, Ming
    Song, Haiyan
    Zhang, Weiguang
    CHEMOSPHERE, 2021, 264 (264)
  • [24] Identification of CYP isozymes involved in benzbromarone metabolism in human liver microsomes
    Kobayashi, Kaoru
    Kajiwara, Eri
    Ishikawa, Masayuki
    Oka, Hidenobu
    Chiba, Kan
    BIOPHARMACEUTICS & DRUG DISPOSITION, 2012, 33 (08) : 466 - 473
  • [25] In Vitro Studies on the Oxidative Metabolism of 20(S)-Ginsenoside Rh2 in Human, Monkey, Dog, Rat, and Mouse Liver Microsomes, and Human Liver S9
    Li, Liang
    Chen, Xiaoyan
    Zhou, Jialan
    Zhong, Dafang
    DRUG METABOLISM AND DISPOSITION, 2012, 40 (10) : 2041 - 2053
  • [26] Drug interactions of paclitaxel metabolism in human liver microsomes
    Bun, SS
    Ciccolini, J
    Bun, H
    Aubert, C
    Catalin, J
    JOURNAL OF CHEMOTHERAPY, 2003, 15 (03) : 266 - 274
  • [27] Effect of benzodiazepines on the metabolism of buprenorphine in human liver microsomes
    Yan Chang
    David E. Moody
    European Journal of Clinical Pharmacology, 2005, 60 : 875 - 881
  • [28] Metabolism and metabolic inhibition of cilnidipine in human liver microsomes
    Liu, XQ
    Zhao, Y
    Li, D
    Qian, ZY
    Wang, GJ
    ACTA PHARMACOLOGICA SINICA, 2003, 24 (03) : 263 - 268
  • [29] Effect of benzodiazepines on the metabolism of buprenorphine in human liver microsomes
    Chang, Y
    Moody, DE
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2005, 60 (12) : 875 - 881
  • [30] Metabolism and Metabolic Inhibition of Xanthotoxol in Human Liver Microsomes
    Ma, Zhongnv
    Shi, Xianbao
    Zhang, Gang
    Guo, Feng
    Shan, Lina
    Cai, Jiqun
    EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE, 2016, 2016